Five years ago, on March 11, the World Health Organization declared COVID-19 a global pandemic. The vaccines “underwent the most intensive safety analysis in U.S. history." ...

AIM Vaccine Co., Ltd., a leading PRC vaccine company, published an announcement on March 9, 2025 , the company's research and ...

Moderna (NasdaqGS:MRNA) saw an 11% increase in share price over the last week, likely influenced by recent legal and financial developments. The announcement of multiple international lawsuits from ...

designed to protect against RSV and COVID-19. Beyond vaccines, pharma is looking to develop mRNA vaccines to treat diseases requiring protein expression, such as cancer. Cancer has proved to be a ...

CompanyOverview\|NASDAQ:MRNA] The CEO of Moderna Inc. (NASDAQ: MRNA) just purchased $5 million of stock in the open market.

This research investigated averted hospitalizations in Oregon and Washington, which had greater than 75% uptake of at least 1 ...

GSK has filed a pair of lawsuits against Moderna, claiming infringement of patents covering mRNA vaccines for COVID-19 and respiratory syncytial virus (RSV). According to court documents ...

Five years after the start of the pandemic, the fight over who owns the underlying technologies that made the Covid-19 ...

Life science companies developing bird flu vaccines are gaining attention as the avian influenza subtype H5N1 becomes an ...

In March 2020, we were bracing for upheavals in our daily lives. COVID-19 had come to our shores, and doctors were at a loss ...

AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on March 9, 2025, the company’s research and development of a diploid rabies vaccine has recently received ...

Moderna stock has surged more than 20% this week after regulatory filings showed several executives bought shares on the open ...